Author:
Bunnik Eline M.,de Jongh Dide,Massey Emma
Abstract
Regenerative medicine is the new frontier in the field of organ transplantation. Research groups around the world are using regenerative medicine technologies to develop bio-artificial organs for transplantation into human patients. While most of this research is still at the preclinical stage, bio-artificial organ technologies are gearing up for first-in-human clinical trials in the not-too-distant future. What are the ethical conditions under which early-phase clinical research of bio-artificial organs can be conducted safely and responsibly? What lessons can be learned from prior experiences with early-phase clinical trials in adjacent fields of research? This is a Meeting Report of an online international workshop organised in the context of the Horizon 2020-funded VANGUARD project, which is developing a bio-artificial pancreas for the treatment of patients with type 1 diabetes.
Reference31 articles.
1. What Makes Clinical Research Ethical?;Emanuel;JAMA,2000
2. Regenerative Medicine, Organ Bioengineering and Transplantation;Edgar;Br J Surg,2020
3. History of Gene Therapy;Wirth;Gene,2013
4. The Structure of Clinical Translation:Efficiency, Information, and Ethics;Kimmelman;Hastings Cent Rep,2015
5. A Theoretical Framework for Early Human Studies: Uncertainty, Intervention Ensembles, and Boundaries;Kimmelman;Trials,2012
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献